ANIXA BIOSCIENCES, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ANIXA BIOSCIENCES, INC. (ANIX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.27 million shares for the 3-month period ending 2020-07-31, per its 10-Q filed 2020-09-08.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2020-09-08
- ANIXA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-07-31 was 7.27M shares, a 1233.70% increase year-over-year.
- ANIXA BIOSCIENCES, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2019-07-31 was 545.00K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|
| 2020-07-31 | 7.27M shares 10-Q · filed 2020-09-08 | 8.10M shares 10-Q · filed 2020-09-08 |
| 2019-07-31 | 545.00K shares 10-Q · filed 2020-09-08 | 500.00K shares 10-Q · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |